DekaBank Deutsche Girozentrale’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-42,000
| Closed | -$215K | – | 1417 |
|
|
2021
Q3 | $215K | Hold |
42,000
| – | – | ﹤0.01% | 1197 |
|
|
2021
Q2 | $181K | Hold |
42,000
| – | – | ﹤0.01% | 1240 |
|
|
2021
Q1 | $209K | Hold |
42,000
| – | – | ﹤0.01% | 1176 |
|
|
2020
Q4 | $215K | Buy |
+42,000
| New | +$215K | ﹤0.01% | 1171 |
|
|
2019
Q3 | – | Sell |
-89,000
| Closed | -$355K | – | 991 |
|
|
2019
Q2 | $355K | Buy |
89,000
+64,500
| +263% | +$257K | ﹤0.01% | 958 |
|
|
2019
Q1 | $265K | Sell |
24,500
-20,000
| -45% | -$216K | ﹤0.01% | 1005 |
|
|
2018
Q4 | $216K | Buy |
44,500
+20,000
| +82% | +$97.1K | ﹤0.01% | 958 |
|
|
2018
Q3 | $265K | Hold |
24,500
| – | – | ﹤0.01% | 1027 |
|
|
2018
Q2 | $294K | Hold |
24,500
| – | – | ﹤0.01% | 997 |
|
|
2018
Q1 | $257K | Buy |
+24,500
| New | +$257K | ﹤0.01% | 959 |
|